The global inhaled nitric oxide delivery systems market is on track for substantial growth, driven by the surging demand for iNO therapy in treating respiratory illnesses. According to a recent market analysis, was estimated to be worth around US$ 273.7 million. The market is anticipated to reach a value of approximately US$ 735.7 million by 2032, …